Clinical Trials Browser

Has results × Melanoma × ALT-803 × Clear all

NCT01946789 2025-01-22

A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors

Phase 1 Completed

26 enrolled 22 charts

Melanoma, Neoplasm Metastasis, Neoplasms